THE CHRISTIE PHARMACY LIMITED
Get an alert when THE CHRISTIE PHARMACY LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-12-31 (in 7mo)
Last filed for 2025-03-31
Confirmation statement due
2026-10-23 (in 5mo)
Last made up 2025-10-09
Watchouts
None on the register
Cash
£750K
-12.6% vs 2024
Net assets
£2M
+11.6% highest in 5 filed years
Employees
63
+18.9% highest in 5 filed years
Profit before tax
£302K
-35.1% vs 2024
Net assets
5-year trend · vs Industrials median
Accounts
5-year trend · latest reflected 2025-03-31
| Metric | Trend | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Turnover | £51,168 | £56,267,000 | £65,663,000 | £77,910,000 | £88,662,000 | |
| Operating profit | £256 | £576,000 | £477,000 | £503,000 | £323,000 | |
| Profit before tax | £241 | £568,000 | £475,000 | £465,000 | £302,000 | |
| Net profit | — | — | — | £349,000 | £225,000 | |
| Cash | £1,315 | £1,296,000 | £458,000 | £858,000 | £750,000 | |
| Total assets less current liabilities | £1,053 | £1,204,000 | £1,589,000 | £2,094,000 | £2,163,000 | |
| Net assets | £743 | £1,204,000 | £1,589,000 | £1,938,000 | £2,163,000 | |
| Equity | £743 | £1,204,000 | £1,589,000 | £1,938,000 | £2,163,000 | |
| Average employees | 43 | 41 | 40 | 53 | 63 | |
| Wages | — | — | — | £1,861,000 | £2,293,000 | |
| Directors' remuneration | — | — | — | £3,000 | £3,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2024 → FY2025 · period ending 2025-03-31 vs 2024-03-31
-
Turnover
+13.8%
£77,910,000 £88,662,000
highest in 5 filed years
-
Cash
-12.6%
£858,000 £750,000
-
Net assets
+11.6%
£1,938,000 £2,163,000
highest in 5 filed years
-
Employees
+18.9%
53 63
highest in 5 filed years
-
Operating profit
-35.8%
£503,000 £323,000
-
Profit before tax
-35.1%
£465,000 £302,000
-
Wages
+23.2%
£1,861,000 £2,293,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Operating margin | 0.5% | 1.0% | 0.7% | 0.6% | 0.4% | |
| Net margin | — | — | — | 0.4% | 0.3% | |
| Return on capital employed | 24.3% | 47.8% | 30.0% | 24.0% | 14.9% | |
| Gearing (liabilities / total assets) | — | — | — | 75.4% | 73.4% | |
| Current ratio | — | — | — | 1.36x | 1.36x | |
| Interest cover | 17.07x | 72.00x | 238.50x | 12.57x | 15.38x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Grant Thornton UK LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Christie NHS Foundation Trust has confirmed its commitment to The Christie Pharmacy Company. This, along with the Board's review of the 2025/26 and 2026/27 financial plan and cash flow, which predict stable profits, net current assets and positive cashflow, has confirmed the Company's status as a going concern.”
Significant events
- “A loss of stock due to a refrigeration failure.”
- “Additional growth in dispensing fees is anticipated because of increased dispensing activity that will result from the adoption of a large clinical service from a neighbouring hospital Trust from 1st April 2025.”
- “A General Pharmaceutical Council inspection in January 2025 for an additional premises registration licence application was successful, and a new licence was issued.”
- “A Home Office inspection in April 2024 for the Controlled Drugs licence is still under review, but the company is permitted to continue to operate in the interim.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 8 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CHILD, Paul Damian, Mr. | Director | 2022-02-01 | Jun 1965 | British |
| DUDLEY-SOUTHERN, Roy Malcolm | Director | 2024-10-01 | Nov 1946 | British |
| POSTILL, Richard | Director | 2022-10-18 | Apr 1975 | British |
Show 8 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| AINSWORTH, Robert David | Director | 2017-10-26 | 2024-09-30 |
| DUNCOMBE, Robert Mark Pigott | Director | 2017-10-23 | 2021-09-01 |
| ELSEY, Rob | Director | 2021-09-01 | 2022-02-01 |
| HACKER, Liesl | Director | 2021-08-02 | 2022-10-18 |
| HACKER, Liesl Ann | Director | 2019-01-31 | 2019-09-05 |
| LARKIN, Joanne | Director | 2019-09-05 | 2020-02-07 |
| PARKINSON, Sally Jane | Director | 2020-03-18 | 2021-08-02 |
| THOMSON, James | Director | 2017-10-23 | 2019-01-31 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| The Christie Nhs Foundation Trust | Legal person | Shares 75–100%, Voting 75–100%, Appoints directors | 2017-10-23 | Active |
Filing timeline
Last 20 of 36 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-10-09 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-06-25 | AA | accounts | Accounts with accounts type full | |
| 2024-10-16 | AA | accounts | Accounts with accounts type full | |
| 2024-10-10 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-10-02 | AP01 | officers | Appoint person director company with name date | |
| 2024-10-02 | TM01 | officers | Termination director company with name termination date | |
| 2023-12-15 | AA | accounts | Accounts with accounts type total exemption full | |
| 2023-10-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-11-27 | AA | accounts | Accounts with accounts type total exemption full | |
| 2022-10-19 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-10-18 | TM01 | officers | Termination director company with name termination date | |
| 2022-10-18 | AP01 | officers | Appoint person director company with name date | |
| 2022-02-01 | AP01 | officers | Appoint person director company with name date | |
| 2022-02-01 | TM01 | officers | Termination director company with name termination date | |
| 2021-10-11 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-09-01 | TM01 | officers | Termination director company with name termination date | |
| 2021-09-01 | AP01 | officers | Appoint person director company with name date | |
| 2021-08-09 | TM01 | officers | Termination director company with name termination date | |
| 2021-08-09 | AP01 | officers | Appoint person director company with name date | |
| 2021-06-29 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.